EUVIMEDEUVIMED entdecken
Crossref

Realizing the Familial Benefits of Genetic Testing: Challenges in Cascade Screening Implementation

Nora Beidler Henrikson, Sukh Makhnoon

Stanford Digital Repository · 01.01.2025

DOI: 10.25936/582a-g331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stanford Digital Repository, erschienen am 01.01.2025. Verfasst von Nora Beidler Henrikson und 1 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic health information is relevant to the care of individual patients (probands) and, potentially, their biological relatives. Cascade screening is the process of systematically identifying at risk relatives who may have a hereditary condition by offering genetic testing within the family of a proband with a known pathogenic variant. It is standard of care for several hereditary conditions for which clinical intervention can either reduce risk or facilitate early identification, such as hereditary breast and ovarian cancer, hereditary colorectal cancer, and familial hypercholesterolemia. In countries with health systems that focus on individual doctor-patient relationships and maximal patient autonomy, such as the United States, probands are responsible for notifying their relatives and recommending cascade screening. Efforts to support probands by providing family letters or educational materials have typically found only incremental improvements in cascade screening uptake. A large body of research suggests that many relatives are never informed and thus lack the opportunity to pursue cascade screening. Research to date suggests that notification strategies that involve direct outreach to biological relatives result in higher cascade screening compared to patient-mediated strategies. Importantly, these health system-led programs should complement—not replace—efforts to support probands in communicating and disclosing risk to their relatives. Direct contact strategies improve health outcomes and save lives. The optimal design and implementation of direct contact programs is still evolving. Several implementation considerations in the cascade screening context are relevant. These include patient and family preferences; public health, health care, and legal landscapes that are not designed for sharing genetic information within families; obligations to preserve proband autonomy, relative autonomy, privacy, and right not to learn about genetic risk; unequal access to genetic counseling and testing; and existing workload and competing demands of clinicians delivering genomic care. This collection provides insight into these issues, which are all critical to realizing the health benefits of cascade screening programs. It presents ethical frameworks that can guide the expansion of individual patient care models to include relational and public health ethics approaches. We include legal scholarship that suggest that direct contact of relatives is permissible under the HIPAA privacy rule with patient consent and that a public health reportable-disease approach is unlikely to be feasible in the U.S. Other included works assess cascade screening in the context of a deceased proband, explore traceback approaches that involve retrospective identification and cascade screening of relatives long after the proband’s initial diagnosis. The included papers also highlight the broad acceptability of direct contact strategies to probands and relatives and offer some guiding principles for the design of such programs. The persistent unequal access to genetic testing and counseling broadly helps underscore the importance of equitable design and implementation of cascade screening programs. Finally, we include efforts to bring implementation science study designs, theories, and frameworks to cascade screening, which can help optimize implementation outcomes such as adoption and sustainability.

Schlagwörter

hereditary cancerhereditary breast and ovarian cancerhereditary colorectal cancerfamilial hypercholesterolemiagenetic information disclosureHIPAA Privacy Ruleimplementation scienceimplementation barriers

Zitieren

APA

Henrikson, N. B., & Makhnoon, S. (2025). Realizing the Familial Benefits of Genetic Testing: Challenges in Cascade Screening Implementation. Stanford Digital Repository. https://doi.org/10.25936/582a-g331

Vancouver

Henrikson NB, Makhnoon S. Realizing the Familial Benefits of Genetic Testing: Challenges in Cascade Screening Implementation. Stanford Digital Repository. 2025. doi:10.25936/582a-g331

BibTeX
@article{Henrikson2025,
  author = {Henrikson, Nora Beidler and Makhnoon, Sukh},
  title = {Realizing the Familial Benefits of Genetic Testing: Challenges in Cascade Screening Implementation},
  journal = {Stanford Digital Repository},
  year = {2025},
  doi = {10.25936/582a-g331}
}
Kostenlos starten →